3.53
+2.62%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About OraSure Technologies
From its filings with the US Securities and Exchange Commission
OraSure Technologies is based in Bethlehem, Pennsylvania and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker OSUR. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 31 December 2025, it reported revenue of $115.0m and a net loss of $68.7m. At that date it held total assets of $403.2m and shareholders' equity of $340.8m. By region, United States accounted for 68.0%, followed by Africa at 20.9% and Europe at 6.4%.
OTI transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are.
Our products and services reside under one reporting hierarchy, with commercial and innovation teams, which are part of a single business unit covering multiple product lines. Our business is principally comprised of the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions.
In November 2025, the Company acquired BioMedomics, Inc. ("BioMedomics"). BioMedomics' SickleSCAN® test is the world's first rapid point-of-care test for sickle cell disease. The SickleSCAN® test is currently sold in markets outside the U.S.
The Company's business consists of the development, manufacture, marketing, sale and distribution of simple, easy to use diagnostic products and specimen collection devices using its proprietary technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. Our diagnostic products include tests for diseases including HIV, Hepatitis C virus (“HCV”), Syphilis, Sickle Cell and COVID-19 that are performed on a rapid basis at the point of care. These products are sold in the United States and internationally to various clinical laboratories, hospitals, clinics, community-based organizations, and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities.
Quoted from its 10-K, filed 9 Mar 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 17 Nov 1986
- Employees
- 500
- Website
- orasure.com ↗
- Head office
- 220 E FIRST ST, BETHLEHEM, PA, 18015
- Incorporated in
- DE
- Classification
- Surgical & Medical Instruments & Apparatus
- Filer status
- Accelerated filer
Leadership
Pay as last reported
- Ms. Mara AspinallIndependent Chairman of the Board$219,998
- Ms. Carrie Eglinton MannerPresident, Chief Executive Officer, Director, since 2022$5.6m
- Mr. Kenneth McgrathChief Financial Officer$1.7m
- Ms. Anne MessingChief Commercial Officer
- Dr. Nancy GaglianoIndependent Director, since 2021$193,333
- Mr. John KennyIndependent Director$119,110
- Mr. Lelio MarmoraIndependent Director$170,000
- Mr. Robert McmahonIndependent Director$180,000
- Hon Dr. David ShulkinIndependent Director$170,000
- Mr. Jason PlagmanVice President - Investor Relations, since 2023
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 45
- Environment
- 24
- Social
- 56
- Governance
- 56
- Direct emissions (scope 1)
- 1,148 t
- Energy emissions (scope 2)
- 1,944 t
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- OraSure Technologies Inc has several strengths that contribute to its success in the market. One notable strength is its strong product portfolio, which includes a range of innovative diagnostic tests and specimen collection devices. These products are highly reliable and have approval from regulatory authorities, offering customers confidence in their effectiveness.
- Another strength is OraSure's commitment to research and development. By continually investing in new technologies and product improvements, the company stays ahead of the competition and can meet the evolving needs of the healthcare industry.
Weaknesses
- Despite its strengths, OraSure Technologies Inc also faces some weaknesses. One significant weakness is its limited market presence outside of certain geographic regions. While the company enjoys strong brand recognition in certain markets, expanding its reach to new regions presents a challenge.
- Additionally, OraSure relies on a few key customers for a significant portion of its revenue. This dependence on a few major clients exposes the company to potential risks if these customers were to reduce their orders or switch to competitors.
Opportunities
- OraSure Technologies Inc has several opportunities to capitalize on in the market. One key opportunity is the growing demand for point-of-care diagnostic tests and their potential integration with telemedicine. By focusing on developing user-friendly and accurate point-of-care solutions, the company can tap into this expanding market segment.
- Another opportunity lies in strategic partnerships and collaborations. By joining forces with other healthcare organizations or technology companies, OraSure can leverage complementary expertise and resources to enhance its product capabilities and enter new markets.
Threats
- OraSure Technologies Inc faces various threats that could hinder its growth and market position. One significant threat is intense competition from both established players and emerging companies. To stay competitive, OraSure must continue to invest in research and development to differentiate itself and maintain its edge in the market.
- Additionally, regulatory challenges and compliance requirements pose a threat to OraSure's operations. Changes in regulations or failure to comply with existing regulations could result in delays, increased costs, or the withdrawal of product approvals.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.